98%
921
2 minutes
20
We aimed to evaluate the reasons for disagreement between screening echocardiography (echo), acquired by nonexperts, and standard echo in the Brazilian primary care (PC). Over 20 months, 22 PC workers were trained on simplified handheld (GE VSCAN) echo protocols. Screening groups, consisting of patients aged 17-20, 35-40 and 60-65 years, and patients referred for clinical indications underwent focused echo. Studies were remotelyinterpreted in US and Brazil, and those diagnosed with major or severe HD were referred for standard echoperformed by an expert. Major HD was defined as moderate to severe valve disease, ventriculardysfunction/hypertrophy, pericardial effusion or wall-motion abnormalities. A random sample of exams wasselected for evaluation of variables accounting for disagreement. A sample of 768 patients was analyzed, 651(85%) in the referred group. Quality issues were reported in 5.8%, and the random Kappa for major HD between screening and standard echo was 0.51. The most frequent reasons for disagreement were: overestimation of mitral regurgitation (MR) (17.9%, N=138), left ventricular (LV) dysfunction (15.7%, N=121), aortic regurgitation (AR) (15.2%, N=117), LV hypertrophy (13.5%, N=104) and tricuspid regurgitation (12.7%, N=98). Misdiagnosis of mitral and aortic morphological abnormalities was observed in 12.4% and 3.0%, and underestimation of AR and MR occurred in 4.6% and 11.1%. Among 257 patients with suspected mild/moderate MR, 129 were reclassified to normal. In conclusion, although screening echo with task-shifting in PC is a promising tool in low-income areas, estimation of valve regurgitation and LV function and size account for considerable disagreement with standard exams.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10554-023-02800-6 | DOI Listing |
Biomed Phys Eng Express
September 2025
Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, Tübingen, Germany.
. Determine the reproducibility of the Clinical (C) aspect of the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification and the duplex ultrasound examination (DUS) for describing an individual's lower extremity chronic venous disorder status..
View Article and Find Full Text PDFPhilos Trans R Soc Lond B Biol Sci
August 2025
Department of Psychology, Kempner Institute for the Study of Natural and Artificial Intelligence, Harvard University, Cambridge, MA, USA.
The question of whether large language models (LLMs) possess Theory of Mind (ToM)-often defined as the ability to reason about others' mental states-has sparked significant scientific and public interest. However, the evidence as to whether LLMs possess ToM is mixed, and the recent growth in evaluations has not resulted in a convergence. Here, we take inspiration from cognitive science to re-evaluate the state of ToM evaluation in LLMs.
View Article and Find Full Text PDFJ Pediatr Soc North Am
August 2025
Stanford School of Medicine Department of Orthopedic Surgery, Palo Alto, CA, USA.
Background: Artificial intelligence (AI) large language models (LLMs) are becoming increasingly popular, with patients and families more likely to utilize LLM when conducting internet-based research about scoliosis. For this reason, it is vital to understand the abilities and limitations of this technology in disseminating accurate medical information. We used an expert panel to compare LLM-generated and professional society-authored answers to frequently asked questions about pediatric scoliosis.
View Article and Find Full Text PDFReprod Biol Endocrinol
August 2025
Gen 5 Fertility Center, San Diego, CA, USA.
Obese or overweight patients considering IVF are generally counselled to reduce weight closer to target BMI (i.e., < 30 kg/m) by interventions entailing dietary change with a structured exercise program.
View Article and Find Full Text PDFPharmacoecon Open
September 2025
Centro Andaluz de Información del Medicamento, Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
Objectives: This study evaluates the efficiency and budgetary impact of trastuzumab deruxtecan (T-DXd) compared with standard therapy in previously treated HER2-low advanced or metastatic breast cancer, from the perspective of the Spanish National Health System.
Methods: A partitioned survival model was developed using data from the DESTINY-BREAST04 trial. Health outcomes were measured in quality-adjusted life years (QALYs) for both the overall population and the hormone receptor-positive (RH+) subgroup.